Abstract
For preservation of its vital functions, the brain is largely dependent of a sufficient delivery of
oxygen and nutrients. Blood flow to the brain is essentially regulated by 2 control mechanisms i.e.
neurovascular coupling and cerebral autoregulation. Cerebral autoregulation aims for constant
adequate blood supply by compensating for blood pressure variations by dilatation or narrowing of
the cerebral microvasculature. Neurovascular coupling adjusts blood supply to the local metabolic
need. Cerebral perfusion and blood flow regulation are compromised in several pathological
conditions. Clinical examination of cerebral blood flow and its regulation may therefore provide
helpful diagnostic, predictive and therapeutic information. The work in this thesis was aimed at
putting a step forward towards development of reliable and clinically usable parameters for cerebral
blood flow regulation assessment using ultrasonography.
Regarding early diagnostics, screening and monitoring of cerebral blood flow and its
regulation, ultrasonography has major advantages over other imaging tools because of its noninvasiveness,
cost-effectiveness, easy usability and its good time resolution. It allows examination of
blood flow velocities at multiple locations throughout the extra- and intracranial circulation and
evaluation of both control mechanisms by transfer function analysis. For evaluation of cerebral
autoregulation, transcranial Doppler blood flow velocities in the large middle cerebral arteries have
been recorded simultaneously with plethysmographic (finger) blood pressure. Gain and phase of the
pressure-flow transfer function have been determined to obtain quantitative measures for cerebral
autoregulation. Neurovascular coupling has been assessed by presenting a visual block stimulus to a
subject and simultaneous measurement of the blood flow velocity in the artery exclusively supplying
the visual cortex. The obtained visually-evoked blood flow response (VEFR) has been considered as
the step response of a linear second order control system model providing patient-specific
parameters such as gain and damping as quantitative measures for neurovascular coupling .
In chapter 2, a clinical study has been described in which extra- and intracranial blood flow
velocities (BFVs), measured at multiple sites in the circulation, have been compared between
Alzheimer patients (AD), patients with mild cognitive impairment (MCI) and healthy aging controls
(HC). BFVs of AD were significantly lowered at proximal sites but preserved at distal sites for the
internal carotid artery and middle and posterior cerebral arteries as compared to those of MCI or HC.
This specific pattern can presumably be ascribed to reduced distal diameters resulting from AD
pathology. MCI BFV were similar to HC BFV in the extracranial and intracranial posterior circulation,
whereas they were intermediate between AD and HC in the intracranial anterior circulation. This
suggests that intracranial anterior vessels are most suitable for early detection of pathological
alterations resulting from AD. The study findings further indicate that extensive ultrasonographic
screening of intra- and extracranial arteries is useful for monitoring BFV decline in the MCI stage.
Future follow-up of MCI patients may reveal the predictive value of location-specific BFV for
conversion to AD.
In the same study cohort, dynamic cerebral autoregulation has been studied as discussed in
chapter 3. Cerebral autoregulatory gain and phase values were similar for AD, MCI and HC which
implies that the cerebral autoregulatory mechanism is preserved in AD. However, the
cerebrovascular resistance index i.e. the ratio between absolute time-averaged blood pressure and
flow velocity, was significantly higher in AD as compared to MCI and HC indicating that vessel
stiffness is increased in AD. Indeed, it appeared to be a potential biomarker for AD development of
MCI. The cerebrovascular resistance increase in AD was furthermore confirmed by windkessel model findings of a significantly elevated peripheral resistance in AD. Arterial resistance and peripheral
compliance were equal for all groups.
From chapter 4, the focus was shifted to assessment of local blood flow regulation. Visuallyevoked
blood flow responses (VEFRs) of formerly (pre-)eclamptic patients and healthy controls have
been examined to evaluate neurovascular coupling first in a relative young study population. The aim
of the study was to investigate whether possible local (pre)eclampsia-induced endothelial damage
was reversible or not. The measured VEFRs have been fitted with the step response of a 2nd order
control system model. Although inter-group differences in model parameters were not found, a
trend was observed that critical damping (z>1) occurred more frequently in former patients than in
controls. Critical damping reflects an atypical VEFR, which is either uncompensated (sluggish, z>1; Tv
<20) or compensated by a rise in rate time (intermediate, z>1; Tv > 20). Since these abnormal VEFRs
were mainly found in former patients (but not exclusively), these response types were hypothesized
to result from pathological disturbances.
A revised VEFR analysis procedure to account for reliability and blood pressure dynamics has
been proposed in chapter 5. This revised procedure consists of the introduction of a reliability
measure for model parameters and of a model extension to consider possible blood pressure
contribution to the measured VEFR. The effects of these adjustments on study outcomes have been
evaluated by applying both the standard VEFR analysis procedure (applied in chapter 4) and the
revised procedure to the AD study cohort. Reliability consideration resulted in about 40% VEFR
exclusion, mainly due to the models’ inability to fit critically damped responses. Reliability
consideration reduced parameter variability substantially. Regarding the influence of blood pressure
variation, a significantly increased damping was found in AD for the standard but not for the revised
model. This reversed the study conclusion from altered to normal neurovascular coupling in AD.
Considering their influence on obtained parameters, both aspects i.e. reliability and blood pressure
variation should be included in VEFR-analysis. Regarding clinical study outcomes, neurovascular
coupling seems to be unaffected in AD since the finding of an increased damping may be ascribed to
ignorance of blood pressure contribution to VEFR.
Study conclusions of earlier chapters (4 and 5) emphasize the need for a model incorporating
physiological features. In chapter 6, preliminary results have been reported of the application of a
newly developed lumped parameter model of the visual cortex vasculature to the 3 different VEFR
types. In the new model, regulatory processes i.e. neurogenic, metabolic, myogenic and shear stress
mechanisms, act on smooth muscle tone which inherently leads to adjustment of microcirculatory
resistance and compliance. This allows the study of effects of pathological changes on the VEFR. It
may be concluded that the model provides an improved link between VEFR and physiology.
Preliminary results show that the physiology-based model can describe VEFR type representatives
reasonably well obtaining physiologically plausible parameter values.
Thus, from a clinical perspective it may be concluded that (Duplex) ultrasonography has great
potential as a standard screening tool for MCI patients. It seems worthwhile to examine all future
MCI patients on extra- and intracranial blood flow velocity and to determine their cerebrovascular
resistance index by simultaneous blood pressure recording. Follow-up of MCI patients will reveal the
predictive value of these parameters for future AD development. Furthermore, from a
methodological perspective, it can be concluded that the current standard of control system analysis
to assess local cerebral blood flow regulation has limitations regarding parameter reliability and VEFR
interpretation. Both reliability and interpretation may be improved by optimization and control of
data acquisition quality and by use of physiology-based models. Physiological mechanisms
influencing VEFR establishment should be incorporated in such a model to possibly explain part of its
variance. Efforts should be directed to development and validation of physiology-based models
aimed at reliable description of VEFRs by physiologically meaningful parameters.
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 14 May 2012 |
| Place of Publication | Eindhoven |
| Publisher | |
| Print ISBNs | 978-90-386-3135-6 |
| DOIs | |
| Publication status | Published - 2012 |